New in FY2027 GLP-1 Medication Coverage for the Treatment of Obesity Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of Fiscal Year 2026 (FY3036), June 30, 2026 for non-Medicare plan members and on December 31, 2026 for Medicare plan members
Folic acid in obstetric practice: a review
These areas typically have a layer of fatty tissue just beneath the skin, which allows the medication to absorb steadily without entering a muscle
Focus on Micronutrients: Since you are eating less, the quality of your food matters more to avoid deficiencies
However, substantial HR reductions were seen among men with patient characteristics similar to the LEADER population, i.e
Pharmaceutical companies are expected to continue refining oral peptide delivery